139 related articles for article (PubMed ID: 11525808)
41. Peripheral neuropathy associated with anti-GM2 ganglioside antibodies: clinical and immunopathological studies.
O'Hanlon GM; Veitch J; Gallardo E; Illa I; Chancellor AM; Willison HJ
Autoimmunity; 2000 Sep; 32(2):133-44. PubMed ID: 11078160
[TBL] [Abstract][Full Text] [Related]
42. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
43. Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-N-tetraose associated with human motor neuron disease.
Latov N; Hays AP; Donofrio PD; Liao J; Ito H; McGinnis S; Konstadoulakis M; Freddo L; Shy ME
Neurology; 1988 May; 38(5):763-8. PubMed ID: 2452383
[TBL] [Abstract][Full Text] [Related]
44. [A case of chronic pure motor neuropathy associated with anti-GalNAc-GD1a-IgM antibody].
Kanzaki A; Endo S; Kusunoki S; Yoshinaga J; Nakamura Y; Shirabe T
No To Shinkei; 2003 Jul; 55(7):609-12. PubMed ID: 12910996
[TBL] [Abstract][Full Text] [Related]
45. Association of IgM type anti-GM1 antibodies and muscle strength in chronic acquired demyelinating polyneuropathy.
Bech E; Andersen H; Orntoft TF; Jakobsen J
Ann Neurol; 1998 Jan; 43(1):72-8. PubMed ID: 9450770
[TBL] [Abstract][Full Text] [Related]
46. Amyotrophic lateral sclerosis with IgM antibody against gangliosides GM2 and GD2.
Mizutani K; Oka N; Kusunoki S; Kaji R; Kanda M; Akiguchi I; Shibasaki H
Intern Med; 2003 Mar; 42(3):277-80. PubMed ID: 12705795
[TBL] [Abstract][Full Text] [Related]
47. Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis.
Pestronk A; Adams RN; Cornblath D; Kuncl RW; Drachman DB; Clawson L
Ann Neurol; 1989 Jan; 25(1):98-102. PubMed ID: 2913936
[TBL] [Abstract][Full Text] [Related]
48. GalNAc-GD1a in human peripheral nerve: target sites of anti-ganglioside antibody.
Kaida K; Kusunoki S; Kamakura K; Motoyoshi K; Kanazawa I
Neurology; 2003 Aug; 61(4):465-70. PubMed ID: 12939418
[TBL] [Abstract][Full Text] [Related]
49. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.
Ogawa G; Kaida K; Kuwahara M; Kimura F; Kamakura K; Kusunoki S
J Neuroimmunol; 2013 Jan; 254(1-2):141-5. PubMed ID: 23000056
[TBL] [Abstract][Full Text] [Related]
50. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
51. Motor neuron syndrome and monoclonal IgM with antibody activity against gangliosides GM1 and GD1b.
Nardelli E; Steck AJ; Barkas T; Schluep M; Jerusalem F
Ann Neurol; 1988 May; 23(5):524-8. PubMed ID: 3389760
[TBL] [Abstract][Full Text] [Related]
52. T cell-independent B cell response to self-monosialogangliosides: primary response monoclonal antibodies.
Alfonso M; Vázquez AM; Carr A; Haerslev T; Fernández LE; Lanio ME; Alvarez C; Zeuthen J; Pérez R
Hybridoma; 1995 Jun; 14(3):209-16. PubMed ID: 7590782
[TBL] [Abstract][Full Text] [Related]
53. Motor neuropathy with activity of monoclonal IgM antibody to GD1a ganglioside.
Bollensen E; Schipper HI; Steck AJ
J Neurol; 1989 Sep; 236(6):353-5. PubMed ID: 2795103
[TBL] [Abstract][Full Text] [Related]
54. Anti-GM1 ganglioside antibodies with differing fine specificities in patients with multifocal motor neuropathy.
Baba H; Daune GC; Ilyas AA; Pestronk A; Cornblath DR; Chaudhry V; Griffin JW; Quarles RH
J Neuroimmunol; 1989 Dec; 25(2-3):143-50. PubMed ID: 2584393
[TBL] [Abstract][Full Text] [Related]
55. Enhanced expression of unique gangliosides with GM2-determinant in human uterine cervical carcinoma-derived cell lines.
Tanaka K; Miyazawa M; Mikami M; Aoki D; Kiguchi K; Iwamori M
Glycoconj J; 2016 Oct; 33(5):745-54. PubMed ID: 27270764
[TBL] [Abstract][Full Text] [Related]
56. Immunoglobulin class switch of anti-ganglioside monoclonal antibody from IgM to IgG.
Shitara K; Fujiwara K; Igarashi S; Ohta S; Furuya A; Nakamura K; Koike M; Hanai N
J Immunol Methods; 1994 Feb; 169(1):83-92. PubMed ID: 8133075
[TBL] [Abstract][Full Text] [Related]
57. Differential immune response to gangliosides in Guillain-Barré syndrome patients from Japan and The Netherlands.
Ang CW; Koga M; Jacobs BC; Yuki N; van der Meché FG; van Doorn PA
J Neuroimmunol; 2001 Dec; 121(1-2):83-7. PubMed ID: 11730944
[TBL] [Abstract][Full Text] [Related]
58. Anti-ganglioside antibodies alter presynaptic release and calcium influx.
Buchwald B; Zhang G; Vogt-Eisele AK; Zhang W; Ahangari R; Griffin JW; Hatt H; Toyka KV; Sheikh KA
Neurobiol Dis; 2007 Oct; 28(1):113-21. PubMed ID: 17720506
[TBL] [Abstract][Full Text] [Related]
59. Delayed motor and sensory neuropathy in a patient with brainstem encephalitis.
Chikakiyo H; Kunishige M; Yoshino H; Asano A; Sumitomo Y; Endo I; Matsumoto T; Mitsui T
J Neurol Sci; 2005 Jul; 234(1-2):105-8. PubMed ID: 15936038
[TBL] [Abstract][Full Text] [Related]
60. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
